Rocket Pharmaceuticals (NASDAQ:RCKT) Rating Lowered to “Sell” at The Goldman Sachs Group
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) was downgraded by The Goldman Sachs Group from a “neutral” rating to a “sell” rating in a note issued to investors on Wednesday, MarketBeat reports. Several other equities analysts have also recently weighed in on RCKT. BMO Capital Markets assumed coverage on Rocket Pharmaceuticals in a research note […]
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) was downgraded by The Goldman Sachs Group from a “neutral” rating to a “sell” rating in a note issued to investors on Wednesday, MarketBeat reports. Several other equities analysts have also recently weighed in on RCKT. BMO Capital Markets assumed coverage on Rocket Pharmaceuticals in a research note […]
